Zuellig Pharma

DR. REDDY'S LABORATORIES (THAILAND) LTD.

Featured products of Dr. Reddy's
abiraterone acetate
Packing/Price
120's
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02BX03 - abiraterone : Belongs to the class of other hormone antagonists and related agents. Used in the treatment of metastatic castration-resistant prostate cancer.
capecitabine
Packing/Price
12 × 10's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BC06 - capecitabine : Belongs to the class of antimetabolites, pyrimidine analogues. Used in the treatment of cancer.
bortezomib
Packing/Price
((lyo)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG01 - bortezomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
rituximab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC02 - rituximab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
rituximab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC02 - rituximab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Distributed by Zuellig Pharma
abiraterone acetate
Packing/Price
120's
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02BX03 - abiraterone : Belongs to the class of other hormone antagonists and related agents. Used in the treatment of metastatic castration-resistant prostate cancer.
capecitabine
Packing/Price
12 × 10's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BC06 - capecitabine : Belongs to the class of antimetabolites, pyrimidine analogues. Used in the treatment of cancer.
bortezomib
Packing/Price
((lyo)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG01 - bortezomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
rituximab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC02 - rituximab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
rituximab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC02 - rituximab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in